molecular pathology


Also found in: Dictionary, Thesaurus, Medical, Legal, Wikipedia.

molecular pathology

[mə′lek·yə·lər pə′thäl·ə·jē]
(pathology)
The study of the bases and mechanisms of disease on a molecular or chemical level.
References in periodicals archive ?
As we aim to ideate the concept of precision medicine in the Molecular Pathology Techniques module, we purposefully introduce the controversial case of Angelina Jolie (Figure 2) for case discussion [17].
Molecular pathology is a new method combining pathology and molecular biology methods.
Headquartered in Maryville, Tennessee, Molecular Pathology Laboratory Network, Inc.
In 2008, the Association for Molecular Pathology (AMP) [2] Economic Affairs Committee (EAC), under the leadership of the late Dr.
Cambridge, United Kingdom, August 29, 2014 --(PR.com)-- The MRC has recently published a thought provoking and comprehensive review of molecular pathology capabilities in the United Kingdom in R&D and healthcare.
Jafarey, the chief guest on the occasion, said that in this era of Molecular Pathology, Gene Chip Technology is the futuristic approach to be adopted by the universities as a priority for disease diagnosis and treatment.
There are five sections: cellular organelle-based renal toxicity; various approaches to toxicity assessment (transcriptomic, proteomic, and metabolomics); approaches to drug-induced renal toxicity, system approaches, and virtual cell; molecular pathology of renal fibrosis and clinical implications of renal toxicity; and classification of nephrotoxicants.
(3) Department of Molecular Pathology, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto 390-8621, Japan
Pharmaceutical Product Development, LLC (PPD) has expanded its central lab testing services in infectious diseases at its Brussels and Singapore labs, offering additional microbiology, peripheral blood mononuclear cell and molecular pathology services.
The case dates back several years, but most recently, the Federal Circuit in August held firm in its July 2011 ruling in Association for Molecular Pathology v.
The biotechnology industry got a boost on July 29 when the Federal Circuit ruled in Association for Molecular Pathology, et al.
On May 12, 2009, the complaint was filed by the Association for Molecular Pathology, et al., by its attorneys, the ACLU and the Public Patent Foundation, alleging that Myriad's patents were invalid under [section] 101, and further alleging a violation of Article I, Section 8, Clause 8 of the United States Constitution, and the First and Fourteenth Amendments to the Constitution.

Full browser ?